by GMFH Editing Team
Faecalibacterium prausnitzii is known for exhibiting anti-inflammatory effects in vitro and in vivo by secreted metabolites that block nuclear factor (NF)-κB activation. The low proportion of F. prausnitzii in the microbiome of Crohn’s disease patients characterizes the microbial dysbiosis associated with that condition.
by Kristina Campbell
Bernd Schnabl, MD, is a practicing physician and associate professor at University of California San Diego. His research focuses on the cellular and molecular mechanisms that contribute to chronic liver disease.
Many disorders are associated with impaired function of the gut barrier. The gut microbiota regulates gut barrier function, and previous research has shown that modulation of gut microbiota shows promise for enhancing barrier integrity.
Many studies are moving beyond investigation of species that are present in the gut, and addressing how the gut microbiota function. How do they achieve, for example, their influence on weight?
by Stefan Jellbauer
Do specific microbiota determine levels of specific metabolites? How does the metabolite profile develop during establishment of the microbiome in infants? Can we assess an individual’s physiological state based on gut flora and metabolites?
by Kristina Campbell
Amir Zarrinpar (MD, PhD) is a gastroenterologist with UC San Diego Health, and a researcher at The Salk Institute for Biological Studies.
by Miguel Angel Valdovinos
The 4th International Symposium on Gut Microbiota in Health and Disease was a success this year, with 946 attendees - more than a third higher than last year.
by Kristina Campbell
In a recent paper, researchers from Canada have coined the term 'ecobiotherapy' to refer to "the use of microbial ecosystems for a therapeutic purpose.
Here is a Storify selection of the best tweets gathered by Julien Tap who attended the recent EMBL Conference: The Human Microbiome, in Heidelberg, Germany, on June 10-12, 2015. ---- [View the story "EMBL Human Microbiome 2015" on Storify]
by Paul Enck
Inflammatory Bowel Disease (IBD) involves aspects of both the host and the microbiota. Previous research in adults shows that IBD is associated with microbiota differences, but little is known about this association in pediatric patients.
